Eric R Olson Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

Eric R Olson is Chief Scientific Officer of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 6,661 shares of SYRS, which is worth approximately $1,332. The most recent transaction as insider was on Jul 17, 2023, when has been sold 689 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $2,411. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.66K

0% 3M change

0% 12M change

Total Value Held $1,332

Eric R Olson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2023	SELL Open market or private sale	$2,411 $3.5 p/Share	689 Reduced 9.37%	6,661 Common Stock
Apr 03 2023	SELL Payment of exercise price or tax liability	$1,607 $2.58 p/Share	623 Reduced 7.81%	7,350 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	2,000 Added 20.05%	7,973 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$30,538 $1.12 p/Share	27,266 Reduced 31.34%	59,734 Common Stock
Jan 05 2022	SELL Open market or private sale	$7,662 $3.47 p/Share	2,208 Reduced 100.0%	0 Common Stock
Jul 01 2021	SELL Open market or private sale	$6,460 $5.55 p/Share	1,164 Reduced 100.0%	0 Common Stock
Mar 15 2021	SELL Open market or private sale	$34,357 $9.47 p/Share	3,628 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$3,664 $1.01 p/Share	3,628 Added 50.0%	3,628 Common Stock

ERO

Eric R Olson

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Value

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syros Pharmaceuticals, Inc.

Track Activities on SYRS

Account